Tenax Therapeutics
TENX • NASDAQ • Stock Fundamentals
Tenax Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Christopher T. Giordano, with a market cap of $321.8M.
Market Cap$321.8M
Employees5.0
CEOChristopher T. Giordano
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 12, 2026 · 15 days agoQ1 2026
View reportNext EarningsAug 12, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Tenax Therapeutics FAQ
Common questions about Tenax Therapeutics
Tenax Therapeutics (TENX) has a market capitalization of $321.8M and trades on NASDAQ.
Tenax Therapeutics has approximately 5 employees.